Lucec Tres, S.A. made an offer to acquire an additional 22.73% stake in Clínica Las Condes S.A. (SNSE:LAS CONDES) for CLP 76.1 billion on October 1, 2019. Under the terms of the offer, Lucec Tres, S.A will pay CLP 40,000 per share. Upon completion of the transaction, Lucec Tres would have a 50.1% stake in Clínica Las Condes. The offer will be financed with own resources and external financing. Lucec Tres, S.A. plans to continue with the CLC operations in terms substantially similar to the current ones, but with a special emphasis on improving the management of the clinical centers operated by Clínica Las Condes S.A. The transaction will be submitted to the National Economic Prosecutor's Office for approval. The offer has a duration of 30 calendar days, from October 2, 2019 to November 4, 2019. As of October 16, 2019, the period of validity of the offer was extended from the original date of November 4 until November 5, 2019. Bofill Mir & Alvarez Jana and Bofill Escobar Abogados acted as legal advisors to Lucec Tres, S.A.. Lucec Tres, S.A. completed the acquisition of an additional 22.73% stake in Clínica Las Condes S.A. (SNSE:LAS CONDES) on November 3, 2019. Lucec Tres’s stake in Clínica Las Condes is now increased to 50.1%.